MY144464A - Pyrazole derivatives as protien kinase modulators - Google Patents

Pyrazole derivatives as protien kinase modulators

Info

Publication number
MY144464A
MY144464A MYPI20052573A MYPI20052573A MY144464A MY 144464 A MY144464 A MY 144464A MY PI20052573 A MYPI20052573 A MY PI20052573A MY PI20052573 A MYPI20052573 A MY PI20052573A MY 144464 A MY144464 A MY 144464A
Authority
MY
Malaysia
Prior art keywords
group
nr2r3
carbon atoms
compounds
linker group
Prior art date
Application number
MYPI20052573A
Inventor
Valerio Berdini
Robin Arthur Ellis Carr
Ian Collins
Gordon Saxty
Marinus Leendert Verdonk
Steven John Woodhead
Paul Graham Wyatt
Robert George Boyle
Hannah Fiona Sore
David Winter Walker
Robert Downham
Original Assignee
Astex Therapeutics Ltd
Cancer Rec Tech Ltd
Cancer Res Inst Royal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2004/005464 external-priority patent/WO2005061463A1/en
Application filed by Astex Therapeutics Ltd, Cancer Rec Tech Ltd, Cancer Res Inst Royal filed Critical Astex Therapeutics Ltd
Publication of MY144464A publication Critical patent/MY144464A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE INVENTION PROVIDES COMPOUNDS OF THE FORMULA (Ι) HAVING PROTEIN KINASE B INHIBITING ACTIVITY: WHEREIN A IS A SATURATED HYDROCARBON LINKER GROUP CONTAINING FROM 1 TO 7 CARBON ATOMS, THE LINKER GROUP HAVING A MAXIMUM CHAIN LENGTH OF 5 ATOMS EXTENDING BETWEEN R¹ AND NR²R³ AND A MAXIMUM CHAIN LENGTH OF 4 ATOMS EXTENDING BETWEEN E AND NR²R³, WHEREIN ONE OF THE CARBON ATOMS IN THE LINKER GROUP MAY OPTIONALLY BE REPLACED BY AN OXYGEN OR NITROGEN ATOM; AND WHEREIN THE CARBON ATOMS OF THE LINKER GROUP A MAY OPTIONALLY BEAR ONE OR MORE SUBSTITUENTS SELECTED FROM OXO, FLUORINE AND HYDROXY, PROVIDED THAT THE HYDROXY GROUP WHEN PRESENT IS NOT LOCATED AT A CARBON ATOM A WITH RESPECT TO THE NR²R³ GROUP AND PROVIDED THAT THE OXO GROUP WHEN PRESENT IS LOCATED AT A CARBON ATOM A WITH RESPECT TO THE NR²R³ GROUP; E IS A MONOCYCLIC OR BICYCLIC CARBOCYCLIC OR HETEROCYCLIC GROUP; R1 IS AN ARYL OR HETEROARYL GROUP; AND R², R³, R⁴ AND R⁵ ARE AS DEFINED IN THE CLAIMS. ALSO PROVIDED ARE PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS, METHODS FOR PREPARING THE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS.
MYPI20052573A 2004-06-08 2005-06-07 Pyrazole derivatives as protien kinase modulators MY144464A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57784304P 2004-06-08 2004-06-08
PCT/GB2004/005464 WO2005061463A1 (en) 2003-12-23 2004-12-23 Pyrazole derivatives as protein kinase modulators

Publications (1)

Publication Number Publication Date
MY144464A true MY144464A (en) 2011-09-30

Family

ID=36940507

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20052573A MY144464A (en) 2004-06-08 2005-06-07 Pyrazole derivatives as protien kinase modulators

Country Status (4)

Country Link
AR (1) AR049437A1 (en)
MY (1) MY144464A (en)
SA (1) SA05260179B1 (en)
TW (1) TWI363622B (en)

Also Published As

Publication number Publication date
AR049437A1 (en) 2006-08-02
TW200602046A (en) 2006-01-16
SA05260179B1 (en) 2009-06-14
TWI363622B (en) 2012-05-11

Similar Documents

Publication Publication Date Title
WO2006136837A3 (en) Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
NO20062633L (en) Pyrazole derivatives as protein kinase modulators
UA93883C2 (en) Pyrazine derivatives useful as adenosine receptor antagonists
TW200613297A (en) Pyrazole derivatives
TW200716528A (en) Cyclopropanecarboxamide derivatives
MY139941A (en) Indole derivatives
CY1111069T1 (en) DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES
NO20066015L (en) Fused heterocyclic compounds
TNSN07397A1 (en) Acetylene derivatives
AR047531A1 (en) DERIVATIVES 1H-TIENO (2,3-C) PIRAZOL USEFUL AS QUINASE INHIBITORS
EA201101566A1 (en) IMIDAZOL DERIVATIVES AND THEIR APPLICATION AS CYLIN-dependent KINAZ MODULATORS
ATE508747T1 (en) C-KIT KINASE INHIBITORS
CY1115171T1 (en) MEDICAL MEDICINE
ID27535A (en) PIRASOLA DURATION AS P-38 MAP KINASE INHIBITOR
WO2007125315A3 (en) Pharmaceutical compounds
BR122017028096B8 (en) compound, pharmaceutical composition, and use of the compound
EA200601830A1 (en) ORT-SUBSTITUTED ARYL OR HETEROARYL AMIDAL COMPOUNDS
MX2010000658A (en) Pyrimidine derivatives 934.
MY150269A (en) Novel phenylpyrrole derivative
CY1113812T1 (en) HYDROCYCLIC UNION AND PHARMACEUTICAL COMPOSITION
MX344276B (en) Novel piperidine compound or salt thereof.
DE602005023544D1 (en) ANGIOGENESIS INHIBITORS
DE60103136D1 (en) IMIDAZOLE DERIVATIVES AS RAF KINASE INHIBITORS
ATE541839T1 (en) PYRROLIDINIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS
GB0501964D0 (en) Chemical compounds